The evolution of microarrayed compound screening

被引:19
作者
Hoever, M [1 ]
Zbinden, P [1 ]
机构
[1] Discovery Partners Int AG, CH-4123 Allschwil, Switzerland
关键词
D O I
10.1016/S1359-6446(04)03037-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review describes recent developments in the evolutionary process of microarrayed compound screening (muARCS(TM)) to become a robust and efficient ultra-high-throughput screening technology. Improvements in compound spotting (including new quality-control methods), gel casting and imaging, together with software capable of automatic analysis and deconvolution of images, have helped to streamline the screening process. A variety of screening projects using cell-based and non-cell-based approaches have been successfully concluded using muARCS. Comparison of hits derived from standard microtitre-plate-based screening and from muARCS reveals excellent overlap. Furthermore, there seems to be no bias towards finding compounds within a particular range of log P values, even though compounds are solubilized from a dry state during the course of the assay.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 22 条
[1]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[2]  
Burns DJ, 2001, DRUG DISCOV TODAY, V6, pS40
[3]   Fulfilling the promise: drug discovery in the post-genomic era [J].
Chanda, SK ;
Caldwell, JS .
DRUG DISCOVERY TODAY, 2003, 8 (04) :168-174
[4]   Studies on repository compound stability in DMSO under various conditions [J].
Cheng, XH ;
Hochlowski, J ;
Tang, H ;
Hepp, D ;
Beckner, C ;
Kantor, S ;
Schmitt, R .
JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (03) :292-304
[5]  
Curtin M, 2002, BIOTECHNIQUES, P107
[6]   Microarray compound screening (μARCS) to identify inhibitors of HIV integrase [J].
David, CA ;
Middleton, T ;
Montgomery, D ;
Ben Lim, H ;
Kati, W ;
Molla, A ;
Xuei, XL ;
Warrior, U ;
Kofron, JL ;
Burns, DJ .
JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (03) :259-266
[7]   Utilization of microarrayed compound screening (μARCS) to identify inhibitors of p56lck tyrosine kinase [J].
Freiberg, G ;
Wilkins, J ;
David, C ;
Kofron, J ;
Jia, Y ;
Hirst, GC ;
Burns, DJ ;
Warrior, U .
JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (01) :12-21
[8]   A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors [J].
Gopalakrishnan, SM ;
Moreland, RB ;
Kofron, JL ;
Helfrich, RJ ;
Gubbins, E ;
McGowen, J ;
Masters, JN ;
Donnelly-Roberts, D ;
Brioni, JD ;
Burns, DJ ;
Warrior, U .
ANALYTICAL BIOCHEMISTRY, 2003, 321 (02) :192-201
[9]   Application of micro arrayed compound screening (μARCS) to identify inhibitors of caspase-3 [J].
Gopalakrishnan, SM ;
Karvinen, J ;
Kofron, JL ;
Burns, DJ ;
Warrior, U .
JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (04) :317-323
[10]  
GOPALAKRISHNAN SM, 2003, SBS 9 ANN C EXH DRUG